Editorial: Insights, controversies, and new developments in the initial treatment decisions for advanced epithelial ovarian cancer

Editorial: Insights, controversies, and new developments in the initial treatment decisions for advanced epithelial ovarian cancer

Saved in:

Bibliographic Details
Main Author:	Jianfeng Guo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Series:	Frontiers in Oncology
Subjects:	epithelial ovarian cancer (EOC) initial treatment decisions machine learning in oncology homologous recombination deficiency (HRD) patient-derived organoids (PDOs) platinum resistance
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1568579/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Whole exome sequencing-based homologous recombination deficiency test for epithelial ovarian cancer
by: Ying-Cheng Chiang, et al.
Published: (2025-01-01)

BRCA loss of function including BRCA1 DNA-methylation, but not BRCA-unrelated homologous recombination deficiency, is associated with platinum hypersensitivity in high-grade ovarian cancer
by: Heidelinde Fiegl, et al.
Published: (2024-11-01)

Development of model for identifying homologous recombination deficiency (HRD) status of ovarian cancer with deep learning on whole slide images
by: Ke Zhang, et al.
Published: (2025-03-01)

Homologous recombination deficiency (HRD) tests for ovarian cancer: a multicenter French phase II study (HERO)
by: Raphaël Leman, et al.
Published: (2025-07-01)

Immunohistochemical Expression of p53 in Epithelial Ovarian Carcinoma and Its Correlation with Clinicopathological Parameters
by: Farzana Sharmin, et al.

Homologous recombination deficiency score is an independent prognostic factor in esophageal squamous cell carcinoma
by: Yulu Wang, et al.
Published: (2024-11-01)

Analysis of homologous recombination deficiency in prostate cancer
by: A. G. Iyevleva, et al.
Published: (2025-03-01)

Preliminary evaluation of ShallowHRD performance compared to HRDetect in familial breast cancer tumors
by: Louise Adel Jensen, et al.
Published: (2025-08-01)

Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer
by: Elena Conca, et al.
Published: (2025-08-01)

Homologous recombination deficiency (HRD) testing landscape: clinical applications and technical validation for routine diagnostics
by: Andréa Witz, et al.
Published: (2025-02-01)

Small extracellular vesicle-based one-step high-throughput microfluidic platform for epithelial ovarian cancer diagnosis
by: Yu Wu, et al.
Published: (2025-04-01)

CT-based radiomics predicts HRD score and HRD status in patients with ovarian cancer
by: Yujiao Wu, et al.
Published: (2025-01-01)

The techniques and applications of patient-derived head and neck cancer organoids: a systematic review
by: Yangyang Xia, et al.
Published: (2025-03-01)

The role of HERV envelope protein in ovarian cancer
by: Jianhao Zhang, et al.
Published: (2025-07-01)

Deep learning based on ultrasound images to predict platinum resistance in patients with epithelial ovarian cancer
by: Chang Su, et al.
Published: (2025-05-01)

Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD Assessment
by: Giovanni Luca Scaglione, et al.
Published: (2025-05-01)

RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancer
by: Kyle C. Strickland, et al.
Published: (2025-08-01)

The organoid: A research model for ovarian cancer
by: Yu-Hsun Chang, et al.
Published: (2022-01-01)

Prognostic and Predictive Value of Systemic Inflammatory Markers in Epithelial Ovarian Cancer
by: Cem İdrisoğlu, et al.
Published: (2025-02-01)

CT-based radiomics model to predict platinum sensitivity in epithelial ovarian carcinoma: a multicentre study
by: Mengge He, et al.
Published: (2025-07-01)

The application of organoids in investigating immune evasion in the microenvironment of gastric cancer and screening novel drug candidates
by: Liuyue Kan, et al.
Published: (2025-04-01)

Circulating proteins and metabolites panel for noninvasive preoperative diagnosis of epithelial ovarian cancer
by: Yan Jia, et al.
Published: (2025-08-01)

Real-world experience and prognostic factors in ovarian carcinosarcoma: a single-center retrospective study from China
by: Wanwan Ji, et al.
Published: (2025-06-01)

The evolving role of PARP inhibitors in advanced ovarian cancer
by: Levva Sofia, et al.
Published: (2021-08-01)

Estrogen regulates PDPK1 to promote cell proliferation in epithelial ovarian cancer
by: Yajie Wang, et al.
Published: (2024-11-01)

Functional validation of somatic variability in TP53 and KRAS for prediction of platinum sensitivity and prognosis in epithelial ovarian carcinoma patients
by: Al Obeed Allah Mohammad, et al.
Published: (2025-12-01)

Combining molecular characteristics and therapeutic analysis of PDOs predict clinical responses and guide PDAC personalized treatment
by: Peng Li, et al.
Published: (2025-02-01)

Joint inference of mutational signatures from indels and single-nucleotide substitutions reveals prognostic impact of DNA repair deficiencies
by: Patricia Ferrer-Torres, et al.
Published: (2025-07-01)

Bevacizumab in Platinum-Sensitive Recurrent Epithelial Ovarian Cancer: A Risk-Stratified Analysis
by: İrem Öner, et al.
Published: (2025-06-01)

Pan-cancer analysis of homologous recombination deficiency and homologous recombination repair–associated gene alterations in solid tumors from a large Asian cohort
by: Lili Ren, et al.
Published: (2025-05-01)

Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer
by: Michal M Hoppe, et al.
Published: (2021-03-01)

Mendelian randomization analysis of CpG methylation and immune phenotypes in epithelial ovarian cancer outcomes
by: Jiawei Li, et al.
Published: (2025-12-01)

Recent Developments in Rare Ovarian Carcinosarcoma: Literature Review and Case Report
by: Alexandra Nienhaus, et al.
Published: (2025-05-01)

Over Two Years of Sustained Remission With Olaparib Monotherapy in Stage IV Non‐Small Cell Lung Cancer With ATM Mutation: A Case Report
by: Zhiting Tang, et al.
Published: (2025-07-01)

The trajectory of conditional, recurrence-free, and long-term survival in a complete 10-year cohort of patients with advanced ovarian cancer
by: Nina Groes Kofoed, et al.
Published: (2025-03-01)

Immuno-reactivity of Engrailed (EN)-2 in Epithelial Ovarian Neoplasms
by: Noha Hassab El-Naby, et al.
Published: (2025-06-01)

Targeting the SPC25/RIOK1/MYH9 Axis to Overcome Tumor Stemness and Platinum Resistance in Epithelial Ovarian Cancer
by: Xingyu Jiang, et al.
Published: (2024-12-01)

Efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in the treatment of platinum resistant recurrent ovarian cancer: a retrospective observational study
by: Alexandra R. Steck, et al.
Published: (2025-08-01)

Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
by: Wang Caixia, et al.
Published: (2025-01-01)

Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study
by: Tamaki Tanaka, et al.
Published: (2025-06-01)